<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Journal of Blood and Cancer</title>
<title_fa></title_fa>
<short_title>Iranian Journal of Blood and Cancer</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijbc.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2008-4595</journal_id_issn>
<journal_id_issn_online>2008-4609</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.61882/ijbc</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>2008-4595</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1401</year>
	<month>9</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2022</year>
	<month>12</month>
	<day>1</day>
</pubdate>
<volume>14</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>The long-term outcome and efficacy of PR1/BCR-ABL multipeptides vaccination in chronic myeloid leukemia: results of a 7-year longitudinal investigation</title>
	<subject_fa>Adults Hematology &amp; Oncology</subject_fa>
	<subject>Adults Hematology &amp; Oncology</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;line-height:2;&quot;&gt;&lt;span style=&quot;font-size:14px;&quot;&gt;&lt;span style=&quot;font-family:Arial;&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;b&gt;Background:&lt;/b&gt; Although Imatinib has revolutionized the treatment of chronic myeloid leukemia (CML), not all patients reach complete remission and a considerable proportion of the patients develop resistance to Imatinib.&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;b&gt;Material and Methods:&lt;/b&gt; In an attempt to increase the tail on the survival curve, we conducted a Phase I/II study of PR1/BCR-ABL multipeptides vaccination trial in CML patients with at least 15 months of Imatinib treatment and 5 &lt;span style=&quot;color:black&quot;&gt;months of persistent molecular residual disease.&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;b&gt;Results: &lt;/b&gt;One month after the completion of the vaccinations&lt;span style=&quot;color:black&quot;&gt;, 4 &lt;/span&gt;patients nearly developed a 1-log fall in their BCR-ABL transcript level, with 4 patients achieving a major molecular response (MMR). Nine patients were followed for more than a period of 7 years. The vaccinations were associated with a MMR in five patients and a complete molecular response (CMR) in one patient. The removal of Imatinib in two patients who achieved MMR after the vaccinations led to a resurgence of the leukemia population and relapse. &lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;b&gt;Conclusion&lt;/b&gt;: Our study suggests that a combination of immunotherapy with Imatinib targeted therapy keeps the leukemia population under control, improving the long-lasting clinical and molecular response of CML patients, for at least 7 years.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Multi-peptide vaccination, BCR-ABL, PR1 peptide, Chronic myeloid leukemia</keyword>
	<start_page>84</start_page>
	<end_page>94</end_page>
	<web_url>http://ijbc.ir/browse.php?a_code=A-10-839-4&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Seyed H.</first_name>
	<middle_name></middle_name>
	<last_name> Ghaffari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>shghaffari200@yahoo.com</email>
	<code>10031947532846008885</code>
	<orcid>10031947532846008885</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ebrahim </first_name>
	<middle_name></middle_name>
	<last_name>Osfouri</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Ebrahimosfouri@yahoo.com</email>
	<code>10031947532846008886</code>
	<orcid>10031947532846008886</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mohammad </first_name>
	<middle_name></middle_name>
	<last_name>Ahmadvand</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846008887</code>
	<orcid>10031947532846008887</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Davood </first_name>
	<middle_name></middle_name>
	<last_name>Bashash</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>David_5980@yahoo.com</email>
	<code>10031947532846008888</code>
	<orcid>10031947532846008888</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Parisa </first_name>
	<middle_name></middle_name>
	<last_name>Ghaffari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846008889</code>
	<orcid>10031947532846008889</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ahmadreza </first_name>
	<middle_name></middle_name>
	<last_name>Niavarani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>ahmadreza.niavarani@gmail.com</email>
	<code>10031947532846008890</code>
	<orcid>10031947532846008890</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Elham </first_name>
	<middle_name></middle_name>
	<last_name>Hossaini</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846008891</code>
	<orcid>10031947532846008891</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Marjan </first_name>
	<middle_name></middle_name>
	<last_name>Yaghmaie</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>marjan_yaghmaie@yahoo.com</email>
	<code>10031947532846008892</code>
	<orcid>10031947532846008892</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Roghieh</first_name>
	<middle_name></middle_name>
	<last_name> Koohi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>koohirora@yahoo.com</email>
	<code>10031947532846008893</code>
	<orcid>10031947532846008893</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Andisheh ie</first_name>
	<middle_name></middle_name>
	<last_name>Ghashgha</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>a-ghashghaie@farabi.tums.ac.ir</email>
	<code>10031947532846008894</code>
	<orcid>10031947532846008894</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Atieh </first_name>
	<middle_name></middle_name>
	<last_name>Pourbagheri-Sigaroodi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>atips1991@gmail.com</email>
	<code>10031947532846008895</code>
	<orcid>10031947532846008895</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Biotechnology, faculty of Advanced Sciences and Technology, Pharmaceutical sciences branch, Islamic Azad University (IAUPS), Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Seyed A. </first_name>
	<middle_name></middle_name>
	<last_name>Mousavi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>a_mousavi@tums.ac.ir</email>
	<code>10031947532846008896</code>
	<orcid>10031947532846008896</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Kamran </first_name>
	<middle_name></middle_name>
	<last_name>Alimoghaddam</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>alimgh@ams.ac.ir</email>
	<code>10031947532846008897</code>
	<orcid>10031947532846008897</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ardeshir </first_name>
	<middle_name></middle_name>
	<last_name>Ghavamzadeh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>ghavamza@sina.tums.ac.ir</email>
	<code>10031947532846008898</code>
	<orcid>10031947532846008898</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Hematologic Malignancies Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
